CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$1,318,032	171,173	-6,615	-3.7%	$7.70	Q4 2025
30 Sep 2025	0%	+0%	$1,310,298	177,788	+15,967	+9.9%	$7.37	Q3 2025
30 Jun 2025	0%	+0%	$647,284	161,821	+131,853	+440%	$4.00	Q2 2025
31 Mar 2025	0%	0%	$95,298	29,968	0		$3.18	Q1 2025
31 Dec 2024	0%	+0%	$160,329	29,968	+14,300	+91%	$5.35	Q4 2024
30 Sep 2024	0%	0%	$82,727	15,668	0		$5.28	Q3 2024
30 Jun 2024	0%	0%	$28,516	15,668	0		$1.82	Q2 2024
31 Mar 2024	0%	0%	$27,889	15,668	0		$1.78	Q1 2024
31 Dec 2023	0%	0%	$27,576	15,668	0		$1.76	Q4 2023
30 Sep 2023	0%	0%	$22,875	15,668	0		$1.46	Q3 2023
30 Jun 2023	0%	+0%	$35,880	15,668	+15,668	NEW	$2.29	Q2 2023
31 Mar 2022		-0%	$0	0	-11,217	-100%	$19.74	Q1 2022
31 Dec 2021	0%	0%	$28,000	11,217	0		$2.50	Q4 2021
30 Sep 2021	0%	+0%	$55,000	11,217	+11,217	NEW	$4.90	Q3 2021
30 Jun 2021		-0%	$0	0	-13,830	-100%	$19.74	Q2 2021
31 Mar 2021	0%	+0%	$43,000	13,830	+13,830	NEW	$3.11	Q1 2021
30 Jun 2019		-0%	$0	0	-36,275	-100%	$19.74	Q2 2019
31 Mar 2019	0%	+0%	$146,000	36,275	+10,375	+40%	$4.02	Q1 2019
31 Dec 2018	0%	0%	$96,000	25,900	0		$3.71	Q4 2018
30 Sep 2018	0%	0%	$223,000	25,900	0		$8.61	Q3 2018
30 Jun 2018	0%	+0%	$285,000	25,900	+8,400	+48%	$11.00	Q2 2018
31 Mar 2018	0%	0%	$202,000	17,500	0		$11.54	Q1 2018
31 Dec 2017	0%	0%	$182,000	17,500	0		$10.40	Q4 2017
30 Sep 2017	0%	0%	$279,000	17,500	0		$15.94	Q3 2017
30 Jun 2017	0%	+0%	$212,000	17,500	+17,500	NEW	$12.11	Q2 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.